Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Systematic review on spheroids from adipose-derived stem cells: Spontaneous or artefact state? | J Cell Physiol | 2022 | 36209478 | PubTator, text mining | PubMed |
| Tissue-specific pathway activities: A retrospective analysis in COVID-19 patients. | Front Immunol | 2022 | 36189295 | PubTator, text mining | PubMed |
| The rationale for the treatment of long-Covid symptoms - A cardiologist's view. | Front Cardiovasc Med | 2022 | 36186977 | PubTator, text mining | PubMed |
| An overview of kinin mediated events in cancer progression and therapeutic applications. | Biochim Biophys Acta Rev Cancer | 2022 | 36167271 | PubTator, text mining | PubMed |
| Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis. | World J Clin Cases | 2022 | 36159543 | PubTator, text mining | PubMed |
| Identification of an amino acid metabolism-associated gene signature predicting the prognosis and immune therapy response of clear cell renal cell carcinoma. | Front Oncol | 2022 | 36158645 | PubTator, text mining | PubMed |
| New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen. | Pharmaceutics | 2022 | 36145659 | PubTator, text mining | PubMed |
| Fludarabine, a Potential DNA-Dependent RNA Polymerase Inhibitor, as a Prospective Drug against Monkeypox Virus: A Computational Approach. | Pharmaceuticals (Basel) | 2022 | 36145351 | PubTator, text mining | PubMed |
| Molecular Bases of Serotonin Reuptake Inhibitor Antidepressant-Attributed Effects in COVID-19: A New Insight on the Role of Bradykinins. | J Pers Med | 2022 | 36143272 | PubTator, text mining | PubMed |
| The Role of Bradykinin Receptors in Hereditary Angioedema Due to C1-Inhibitor Deficiency. | Int J Mol Sci | 2022 | 36142237 | PubTator, text mining | PubMed |
| Renal, cardiac, neurological, cutaneous and coagulopathic long-term manifestations of COVID-19 after recovery; A review. | Epidemiol Infect | 2022 | 36128671 | PubTator, text mining | PubMed |
| SGLT2 inhibitors attenuate nephrin loss and enhance TGF-β1 secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial. | Sci Rep | 2022 | 36127497 | PubTator, text mining | PubMed |
| Opportunities and challenges of pain-related myocardial ischemia-reperfusion injury. | Front Physiol | 2022 | 36117689 | PubTator, text mining | PubMed |
| Bradykinin/bradykinin 1 receptor promotes brain microvascular endothelial cell permeability and proinflammatory cytokine release by downregulating Wnt3a. | J Biochem Mol Toxicol | 2022 | 36111657 | PubTator, text mining | PubMed |
| Modeling the tonotopic map using a two-dimensional array of neural oscillators. | Front Comput Neurosci | 2022 | 36093416 | PubTator, text mining | PubMed |
| The COVID-19 pandemic and Alzheimer's disease: mutual risks and mechanisms. | Transl Neurodegener | 2022 | 36089575 | PubTator, text mining | PubMed |
| Comparing the Neuroprotective Effects of Telmisartan, Perindopril, and Nebivolol Against Lipopolysaccharide-Induced Injury in Neuron-Like Cells. | Cureus | 2022 | 36051740 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the circRNA-miRNA-mRNA network for atrial fibrillation. | Medicine (Baltimore) | 2022 | 36042613 | PubTator, text mining | PubMed |
| Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. | Mol Immunol | 2022 | 36030710 | PubTator, text mining | PubMed |
| Expression profile analysis to identify potential gene changes induced by dexamethasone in the trabecular meshwork. | Int J Ophthalmol | 2022 | 36017046 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=14